HER-2 gene amplification can be acquired as breast cancer progresses - Wikidata - thesis-toulmin - TriplyDB

HER-2 gene amplification can be acquired as breast cancer progresses

HER-2 gene amplification can be acquired as breast cancer progresses

http://www.wikidata.org/entity/Q24563115

about

Circulating tumor cells: approaches to isolation and characterization Circulating tumor cells: finding the needle in the haystack Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models.Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review Circulating tumor cells in breast cancer Characterization of DNA Methylation in Circulating Tumor Cells Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials Dynamic changes in numbers and properties of circulating tumor cells and their potential applications Detection of circulating tumor cells Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications Minimal residual disease and circulating tumor cells in breast cancer Parallel single cancer cell whole genome amplification using button-valve assisted mixing in nanoliter chambers ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study Molecular biomarker analyses using circulating tumor cells Circulating tumor cells: the substrate of personalized medicine?Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.A comparison of RNA amplification techniques at sub-nanogram input concentration.Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.Circulating Tumor Cells in Early-Stage Breast Cancer.Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatment.International study on inter-reader variability for circulating tumor cells in breast cancer The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.HER2-positive circulating tumor cells in breast cancer The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.Circulating tumor cells in breast cancer.uPAR and HER2 Genes Are Usually Co-Amplified in Individual Breast Cancer Cells from Blood and Tissues.Targeted Therapy in Breast Cancer.All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.Circulating tumor cells in non-metastatic triple-negative breast cancer.

P2860

Q24631347-2E21CE26-9A88-48B8-A346-2F9EF88947B0 Q24634952-264FC21C-4632-4F22-9DBC-DDF85DFA1490 Q24813647-A42B3DF5-0E5C-4F2A-8C04-AA2E4A91911F Q25257601-2EAD042C-B6A5-4C52-B9A8-86C5F5B250B9 Q26748850-7F1540CA-A294-4182-8EFA-E59F49D736BC Q26752116-A2FFF32B-DEF4-4EEF-A04C-7D30608AF1B1 Q26774808-AC673D0B-1C52-483C-978E-6335AC8DF9BF Q26778427-70F15946-D065-444A-97B7-F66541248458 Q26827936-56645244-C21B-4B5F-854E-B82A217F2107 Q26853569-90E18983-1F28-46DA-A899-40FA6831B74F Q26859334-AC6C25EE-5483-4EB3-9D11-96FF418A3C74 Q26996059-72B37C61-1DA3-4CDB-85D1-FC6D6162A5AC Q27010152-2E148585-59E7-4034-A6F4-577FEDD0B29A Q27346403-E5D732F9-C637-4871-A60E-B86B6384FB43 Q27852637-5A2FE25E-9664-40EE-87A5-CFC524CB5B7B Q28066285-EDF12574-493E-4985-A983-C66FCCB7F84D Q28067549-6E510430-3585-4687-AF44-0324A98D7E15 Q28535476-FA9B56D2-5E80-41A8-BCB5-F346FC658EAF Q28749394-BEF92B8F-D3F7-4370-8E41-53946EE45FA2 Q30465827-EE155DC1-FADA-4C47-A645-A76E8218AD52 Q31006508-4D454515-F66D-4826-8751-8B87B8BA7756 Q33484382-777543D9-5BDC-4AEA-8D02-555298E87ECE Q33555492-C4CCE99F-01C3-45B1-9DC9-29ECF5ED4273 Q33559406-4082F337-A607-4A2E-B3D7-0CBD5BF9C8E1 Q33579111-56FF4D6F-B3C6-4AA6-B62B-A0E0FA378232 Q33638864-21751AF4-C405-43D9-A9A9-5917442C3054 Q33691179-3B5DA0A0-6E61-4732-B747-EAA5A4DCB00B Q33700933-2A4D7923-2360-42C0-B89E-0321E4CBABFC Q33738688-8640338B-D44C-4BEE-A96E-5039DD6CB811 Q33769034-6338C36B-A45B-4CBE-908C-597D94629DE2 Q33802925-5D81FA00-496F-422F-8ECA-B70308A318D3 Q33815087-648AEC0E-9DE5-4C2E-BF4D-9053BB614E65 Q33820233-39E60872-7CB0-4600-8F87-50DFA9A993ED Q33847889-5FBDE6AE-0323-4FBB-A614-E020D6ABFB45 Q34038793-13B7CA44-B084-4264-9146-003FE987F62D Q34077349-EE661F0D-08B3-4073-A761-952F3D89109E Q34095775-73B3D782-4634-49EA-A379-53BE2745755B Q34096056-0B4A859C-ACF8-4284-A2A9-7F8BFD82DF7B Q34098110-30BFEE63-3465-4615-B2F9-B1BD46F055C3 Q34111867-60DFACE8-FDBE-4D2D-B203-34385A316820

P2860

HER-2 gene amplification can be acquired as breast cancer progresses

http://www.wikidata.org/entity/Q24563115

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

HER-2 gene amplification can be acquired as breast cancer progresses

@ast

HER-2 gene amplification can be acquired as breast cancer progresses

@en

HER-2 gene amplification can be acquired as breast cancer progresses

@nl

type

label

HER-2 gene amplification can be acquired as breast cancer progresses

@ast

HER-2 gene amplification can be acquired as breast cancer progresses

@en

HER-2 gene amplification can be acquired as breast cancer progresses

@nl

prefLabel

HER-2 gene amplification can be acquired as breast cancer progresses

@ast

HER-2 gene amplification can be acquired as breast cancer progresses

@en

HER-2 gene amplification can be acquired as breast cancer progresses

@nl

P1433

Q24563115-88AA53CA-B6D1-4E65-B7F8-C114FF549284

P1476

Q24563115-D838F48F-78DF-4BB8-939C-5C47C16C3D60

P2093

Q24563115-0AB33DED-B4F9-4EB8-897A-5E0EAFBB45BC

Q24563115-18764135-581F-4CE1-83F3-83AC6360E26B

Q24563115-242634F0-B39E-43FE-857C-817FEF060273

Q24563115-27418AA9-08E9-4D83-B455-C849D2C67E34

Q24563115-2C4C7623-5B87-4E21-93C2-2E54CC01CEB3

Q24563115-2ED4FAED-E185-439D-A50B-234DF594689E

Q24563115-2FAF5346-92EF-4C3F-A6E9-3A1D29EB4970

Q24563115-3E728DA7-D265-4341-9BA5-199E73B726D0

Q24563115-6024040E-F9CB-4FA5-9B5D-FCC3309ECEF4

Q24563115-780A7FCA-2D39-45DF-985C-78474FA80C1A

P2860

Q24563115-02F088DB-6F01-4FFA-BAAC-808E2FFF9A6D

Q24563115-0790C331-E201-4D2F-9715-E5774DD357BB

Q24563115-28A2F497-0765-4148-A264-B37C1B2AC5FB

Q24563115-45118B89-C610-4B38-A788-820BE41C0DF4

Q24563115-54BDA281-8602-412C-ADA3-9CEB207AA042

Q24563115-5AF6897F-09A3-4FB4-8A35-F15FF1B8EABC

Q24563115-6932A5A6-5485-4669-95B7-04D5C6E92150

Q24563115-89E369BF-7865-444C-8B4E-A03A072C96F7

Q24563115-A87E02A5-8536-4A82-A87A-BC2E670AF716

Q24563115-E7EB5289-154B-46D5-99F3-E2340D3C6920

P304

Q24563115-8379683B-F3BF-4E3E-93F9-A155CC36F7BE

P31

Q24563115-9088C3F8-26AC-4FFD-AAC7-BF5A9FA19ADA

P3181

Q24563115-51D55D14-EE98-40F8-BB44-4694AE65E388

P356

Q24563115-4524A9BE-55EC-4C05-AB71-09DF02422074

P407

Q24563115-91B34714-7B83-43DE-A9A5-7FDC56B4A540

P433

Q24563115-1991DA44-88BE-40EA-BDA4-90D4607F114A

P478

Q24563115-943A6952-868F-4D96-8406-FC1A44DE342E

P50

Q24563115-5BC41971-91E6-4792-B65F-892AFBC0B27D

Q24563115-8281458F-DEFB-4AE0-B166-2F94ED89415B

P577

Q24563115-807DB49F-5D79-4EC3-BB62-36425B7B6BF4

P5875

Q24563115-39BF2771-85AF-4FF1-9B2C-60121C8F310E

P698

Q24563115-8C32046D-7555-4BDA-A12C-94FD2E107EE1

P932

Q24563115-DB814145-1C0D-49DB-B1F8-9B2A1F306393

P3181

P356

PNAS.0402993101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

HER-2 gene amplification can be acquired as breast cancer progresses

@en

P2093

Amanullah Khan

http://www.w3.org/2001/XMLSchema#string

Barbara Haley

http://www.w3.org/2001/XMLSchema#string

Cynthia Osborne

http://www.w3.org/2001/XMLSchema#string

David Euhus

http://www.w3.org/2001/XMLSchema#string

Debasish Tripathy

http://www.w3.org/2001/XMLSchema#string

Dorothee Herlyn

http://www.w3.org/2001/XMLSchema#string

Edward Clifford

http://www.w3.org/2001/XMLSchema#string

Eugene Frenkel

http://www.w3.org/2001/XMLSchema#string

Jianqiang Wang

http://www.w3.org/2001/XMLSchema#string

Jonathan Uhr

http://www.w3.org/2001/XMLSchema#string

P2860

Detection and characterization of carcinoma cells in the blood

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation.

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

Targeted therapy for cancer: the HER-2/neu and Herceptin story.

Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer

HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.

Her-2/neu status in breast cancer metastases to the central nervous system.

P304

9393-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1588807

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0402993101

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8512369

http://www.w3.org/2001/XMLSchema#string

P698

15194824

http://www.w3.org/2001/XMLSchema#string

P932

438987

http://www.w3.org/2001/XMLSchema#string